Here are three key notes:
1. The system is a minimally invasive interbody fusion device providing integrated fixation.
2. The system is designed for use in patients with degenerative disc disease at 1 or 2 contiguous levels from L2 to S1.
3. The system is intended for use with bone graft and with supplemental fixation systems.
More articles on devices:
Misonix revenue reaches $5.4M in Q3: 8 highlights
RTI Surgical outlines why stockholders should elect its director nominees on WHITE proxy card: 5 points
Stryker, Smith & Nephew, K2M & more: 18 key notes